NEW YORK (Reuters Health) – In patients with newly diagnosed type 1 diabetes, high-dose immune ablation followed by autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) induces significant and…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
NEW YORK (Reuters Health) – Roughly one in five deaths after lumbar fusion surgery is related to analgesic use, according to a report in the April 1st issue…
Rasheed A. Balogun, MD, Associate Professor of Medicine in the Division of Nephrology at the University of Virginia Health System, discusses the risk factors for Chronic Kidney Disease…
NEW YORK (Reuters Health) – Diabetics who use drugs from the glitazone class appear to have a modest increase in risk of developing macular edema, according to study…
NEW YORK (Reuters Health) – Surgically induced weight loss is cost-effective relative to conventional therapy for the management of type 2 diabetes in obese patients, both in the…
NEW YORK (Reuters Health) – High intake of saturated and trans fats along with low intake of polyunsaturated fats is associated with cognitive decline in women with type…
NEW YORK (Reuters Health) – Compared with standard therapy with a nicotine patch, combination therapy with a patch, a nicotine oral inhaler, and bupropion for as long as…
NEW YORK (Reuters Health) – Higher plasma glucose levels are associated with worse outcomes in women with ovarian carcinoma, according to a report in the March 1st Cancer.…
NEW YORK (Reuters Health) – Women with migraines during pregnancy are at increased risk for stroke, MI, and other vascular disorders, according to a report in the March…